NOV (NOV) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Q2 2024 revenue reached $2.22 billion, up 6% year-over-year, driven by strong offshore and international growth, with offshore contributing 44% and international 62% of revenue.
Net income was $226 million ($0.57 per diluted share), up $71 million year-over-year, aided by a $118 million gain from the Pole Products divestiture.
Adjusted EBITDA rose 15% year-over-year to $281 million (12.7% margin), the highest since 2015.
Free cash flow was $350 million, supporting increased shareholder returns and strategic investments.
Bookings surged, with a 177% book-to-bill ratio and backlog at its highest since 2015.
Financial highlights
Cash flow from operations was $432 million; free cash flow reached $350 million; CapEx was $82 million.
Operating profit was $313 million (14.1% margin), up from $181 million in Q2 2023.
Gross profit for Q2 2024 was $590 million (26.6% margin), up from 21.8% a year ago.
Net proceeds from the Pole Products divestiture were $176 million in Q2 2024.
Annualized Q2 2024 revenue was $8.9 billion; annualized adjusted EBITDA was $1.1 billion.
Outlook and guidance
Q3 2024 consolidated revenue expected flat to up low single digits year-over-year; Adjusted EBITDA guidance is $270–$305 million.
Full year 2024 revenue growth anticipated in the low- to mid-single digit percent range; Adjusted EBITDA expected between $1.10 billion and $1.18 billion; CapEx $330 million.
Margin expansion expected into Q4 2024 (targeting ~14%) and further into 2025 as higher-margin backlog replaces legacy contracts.
At least 50% of excess free cash flow to be returned to shareholders via dividends and buybacks.
Management expects continued growth in energy transition markets, with ongoing investments in wind, geothermal, rare earth extraction, biogas, and carbon sequestration.
Latest events from NOV
- Q1 2026 revenue and profit declined due to Middle East disruptions; outlook remains cautious.NOV
Q1 202629 Apr 2026 - Votes sought for nine directors, auditor ratification, and executive pay approval.NOV
Proxy filing9 Apr 2026 - Proxy covers director elections, auditor ratification, executive pay, and strong governance practices.NOV
Proxy filing9 Apr 2026 - 2025 saw strong cash flow and shareholder returns despite lower revenue and a cautious 2026 outlook.NOV
Q4 20255 Feb 2026 - Adjusted EBITDA and cash flow rose despite lower revenue, with strong capital returns and backlog.NOV
Q1 202519 Jan 2026 - Q3 net income up 14% to $130M, with strong offshore demand and record backlog.NOV
Q3 202418 Jan 2026 - 2024 delivered strong growth, cash flow, and backlog; 2025 outlook is flat revenue, higher margins.NOV
Q4 20249 Dec 2025 - Proxy seeks approval for director elections, auditor, executive pay, and expanded equity plan.NOV
Proxy Filing1 Dec 2025 - Key votes on directors, auditor, executive pay, and incentive plan set for May 2025 meeting.NOV
Proxy Filing1 Dec 2025